SCHEMBL146805

SCHEMBL146805

Cc1c(C)c(-c2ccc(C(=O)O)cc2)c(C)c(C)c1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 6/20 0.50
RXRB P28702 5/20 0.50
ALDH1A1 P00352 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TTR P02766 1/20 0.48
TP53 P04637 1/20 0.48
TSHR P16473 1/20 0.48
SRD5A2 P31213 2/20 0.45
BCL2L1 Q07817 1/20 0.45
BAD Q92934 1/20 0.45
HSD17B10 Q99714 1/20 0.43
RXRG P48443 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA3 P07451 1/20 0.41
TYR P14679 1/20 0.41
DRD1 P21728 1/20 0.41
CA4 P22748 1/20 0.41
CA6 P23280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29558263 0.92 ALDH1A1 (0.58) RXRARXRBALDH1A1SMN1; SMN2TTR
SCHEMBL8848509 0.90 RXRA (0.48) RXRARXRBALDH1A1SMN1; SMN2TTR
SCHEMBL24733376 0.87 ALDH1A1 (0.58) RXRARXRBALDH1A1SMN1; SMN2TTR
SCHEMBL16749644 0.86 ALDH1A1 (0.58) RXRARXRBALDH1A1SMN1; SMN2TTR
SCHEMBL27816594 0.83 PDE10A (0.47) ALDH1A1SMN1; SMN2TSHRKDM4EMEN1
SCHEMBL29624164 0.83 ALDH1A1 (0.58) RXRARXRBALDH1A1SMN1; SMN2TTR
SCHEMBL17069702 0.82 RXRA (0.48) RXRARXRBALDH1A1SMN1; SMN2TTR
SCHEMBL28726923 0.80 RXRA (0.55) RXRARXRBALDH1A1SMN1; SMN2TTR
SCHEMBL28708049 0.79 TSHR (0.57) RXRARXRBALDH1A1SMN1; SMN2TTR
SCHEMBL24734312 0.78 RXRA (0.53) RXRARXRBALDH1A1SMN1; SMN2TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076734-B1 COMPOSITE MATERIAL COMBINING MOF NANOPARTICLES AND METAL NANOPARTICLES CENTRE NAT RECH SCIENT (FR) 2024-04-03 EP claimed
EP-4076734-A1 COMPOSITE MATERIAL COMBINING MOF NANOPARTICLES AND METAL NANOPARTICLES Centre national de la recherche scientifique (FR) 2022-10-26 EP claimed
US-11426704-B2 Metal organic frameworks for the capture of volatile organic compounds CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2022-08-30 US claimed
US-20210277042-A1 LOW TEMPERATURE PROCESS FOR THE SYNTHESIS OF MOF CARBOXYLATE NANOPARTICLES UNIVERSITÉ DE VERSAILLES - SAINT-QUENTIN-EN-YVELINES (FR) 2021-09-09 US claimed
EP-3453450-B1 USE OF METAL ORGANIC FRAMEWORKS FOR THE CAPTURE OF ACETIC ACID CENTRE NAT RECH SCIENT (FR) 2021-06-30 EP claimed
WO-2021123570-A1 COMPOSITE MATERIAL COMBINING MOF NANOPARTICLES AND METAL NANOPARTICLES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2021-06-24 WO claimed
US-11034711-B2 Low temperature process for the synthesis of MOF carboxylate nanoparticles CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2021-06-15 US claimed
US-20200269211-A1 METAL ORGANIC FRAMEWORKS FOR THE CAPTURE OF VOLATIL ORGANIC COMPOUNDS ÉCOLE SUPÉRIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS (FR) 2020-08-27 US claimed
EP-3681627-A1 METAL ORGANIC FRAMEWORKS FOR THE CAPTURE OF VOLATIL ORGANIC COMPOUNDS Centre National De La Recherche Scientifique (FR) 2020-07-22 EP claimed
EP-3357929-B1 LOW TEMPERATURE PROCESS FOR THE SYNTHESIS OF MOF CARBOXYLATE NANOPARTICLES CENTRE NAT RECH SCIENT (FR) 2020-06-17 EP claimed
US-20110172412-A1 REDUCIBLE POROUS CRYSTALLINE HYBRID SOLID FOR THE SEPARATION OF MIXTURES OF MOLECULES HAVING DIFFERENT DEGREES AND/OR A DIFFERENT NUMBER OF UNSATURATIONS UNIVERSITE DE CAEN-BASSE NORMANDIE (FR) 2011-07-14 US claimed
US-20110052650-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST Centre National De La Recherche Scientifique - CNR S (FR) 2011-03-03 US claimed
EP-2260048-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST Centre National de la Recherche Scientifique - CNRS (FR) 2010-12-15 EP claimed
WO-2010136677-A1 USE OF A POROUS CRYSTALLINE HYBRID SOLID AS A NITROGEN OXIDE REDUCTION CATALYST AND DEVICES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS (FR) 2010-12-02 WO claimed
US-20100226991-A1 SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS- (FR) 2010-09-09 US claimed
US-20100209354-A1 ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2010-08-19 US claimed
EP-2193137-A1 ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES Centre National De La Recherche Scientifique-CNRS (FR) 2010-06-09 EP claimed
WO-2010058123-A1 METHOD FOR HYDROTHERMAL PREPARATION OF METAL-ORGANIC FRAMEWORK CRYSTALLISED POROUS ALUMINIUM CARBOXYLATES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS- (FR) 2010-05-27 WO claimed
WO-2009133278-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2009-11-05 WO claimed
WO-2009077670-A1 ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2009-06-25 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110052650-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST MITF, SLCO2B1, SLCO2A1 RXRA 1691/4885RXRB 2183/4885ALDH1A1 2972/4885
US-20100226991-A1 SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE SLCO2A1, SLCO4C1, SLCO2B1 RXRA 968/4885RXRB 1769/4885ALDH1A1 150/4885
US-20210277042-A1 LOW TEMPERATURE PROCESS FOR THE SYNTHESIS OF MOF CARBOXYLATE NANOPARTICLES FTO, TPI1, ACP1 RXRA 4670/4885RXRB 4838/4885ALDH1A1 868/4885
US-20110172412-A1 REDUCIBLE POROUS CRYSTALLINE HYBRID SOLID FOR THE SEPARATION OF MIXTURES OF MOLECULES HAVING DIFFERENT DEGREES AND/OR A DIFFERENT NUMBER OF UNSATURATIONS SORBS1, MRPS23, CTCF RXRA 1250/4885RXRB 1713/4885ALDH1A1 4098/4885
US-20100209354-A1 ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES SLC39A3, SLC40A1, AOC3 RXRA 3552/4885RXRB 3981/4885ALDH1A1 488/4885
US-11034711-B2 Low temperature process for the synthesis of MOF carboxylate nanoparticles FTO, TPI1, ACP1 RXRA 4670/4885RXRB 4838/4885ALDH1A1 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.